Israel Englander’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-30,000
Closed -$392K 6251
2024
Q4
$392K Buy
+30,000
New +$400K ﹤0.01% 4917
2024
Q3
Sell
-100,000
Closed -$1.35M 6368
2024
Q2
$1.35M Buy
+100,000
New +$2.05M ﹤0.01% 3872
2024
Q1
Sell
-30,000
Closed -$578K 6515
2023
Q4
$578K Buy
30,000
+9,200
+44% +$167K ﹤0.01% 4553
2023
Q3
$336K Buy
+20,800
New +$369K ﹤0.01% 4871
2018
Q3
Sell
-75,000
Closed -$1.25M 4174
2018
Q2
$1.25M Buy
+75,000
New +$1.21M ﹤0.01% 2692
2018
Q1
Sell
-30,000
Closed -$566K 3960
2017
Q4
$566K Buy
+30,000
New +$665K ﹤0.01% 3025

Other funds holding ACH

Israel Englander's ACH Position: Q2 2026 in Review

Israel Englander reduced its Accendra Health (ACH) stake by 57% in Q2 2026, selling an estimated $848K and leaving 202,018 shares worth $691K. The position accounts for ﹤0.01% of the portfolio, ranked #4564.

Israel Englander first reported a position in ACH in Q2 2013 and has held it in 47 quarters since. The position peaked at $33.1M in Q4 2021. 138 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Israel Englander held 202,018 shares of Accendra Health worth $691K as of Q2 2026.
  • Israel Englander sold 272,770 Accendra Health shares in Q2 2026, an estimated $848K.
  • Accendra Health made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4564 holding.
  • Israel Englander first reported a position in Accendra Health in Q2 2013 and has held it in 47 quarters since.
  • Israel Englander's Accendra Health position peaked at $33.1M in Q4 2021.
  • 138 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.